Never Too Late: if you missed The IPKat last week


Before we start the new week, let's see what the Kats were up to last week...


Art. 53(c) EPC prohibits the grant of European patents in respect of "methods for treatment of the human or animal body by surgery". The EPO Boards of Appeal recently had the opportunity to clarify the boundaries of this provision in a case involving a patent related to tooth replacement technology. Peter Ling provided highlights of the EPO Boards of Appeal’s decision.


Can't believe it's
almost Monday...

The District Court in the Hague made a ruling in the case between Novartis and Mylan, concerning the pharmaceutical Exjade, which is protected by both a patent and subsequently a Supplementary Protection Certificate as well by an Orphan Drug Designation. Novartis sued Mylan for infringement of the SPC (under the term of its Paediatric Extension) on Exjade and Mylan countersued alleging the invalidity of the Paediatric Extension. Frantzeska Papadopoulou reported on the ruling concerning preliminary relief proceedings.


Conventional wisdom says that Dutch courts favour a pragmatic and commercial approach to patent litigation, allowing, where they can, patentees to effectively obtain cross-border injunctions against multiple defendants. The Hague District Court once again proved this conventional wisdom to be true when the Court granted a cross-border preliminary injunction against Mylan in the Novartis SPC battle. Léon Dijkman reported on the Court’s decision.


In the recent decision "data packet transformation" ("Datenpaketumwandlung"), the German Federal Court of Justice had to rule on whether, and under what circumstances, a party can sue for invalidity of a patent after the 20-year term of protection has already expired. Peter Ling reported on the Court’s decision.



Pandemics may have long-term consequences. One such consequence of the coronavirus may be the threat to trust, and more specially, a threat to certification marks. Neil Wilkof provided some info on the probability that certification marks may fall victim to the coronavirus.


Kat friend Jonathan Coote, offers his own thoughts on Glenn Gould, performance, recording, and user rights here.

Never Too Late: if you missed The IPKat last week Never Too Late: if you missed The IPKat last week Reviewed by Magdaleen Jooste on Sunday, November 01, 2020 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here:

Powered by Blogger.